Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diuretic Strategies in Acute Heart Failure (P-Value-AHF)
NCT05986773Phase 4Terminated
- Sponsor
- Stadtspital Zürich
- Start
- Oct 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of furosemide, metolazone, acetazolamide in Acute Heart Failure (AHF), sponsored by Stadtspital Zürich. Started Oct 2023; status: terminated.
02
Drugs
furosemidemetolazoneacetazolamide
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on NCT05986773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05986773.